The page is the record's research on the issuer — no analyst, no rating, no view.

# Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

Mirum Pharmaceuticals, Inc. is listed on NASDAQ under the ticker MIRM, with ISIN US6047491013 and LEI 254900YZKR40F7F27K81. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its listing status is listed, not halted.

## The disclosure read

The record holds 145 filings in the twelve months to 2026-11-08, across 76 filing days. The median gap between filing days is 3 days, against a NASDAQ median of 6.0 days and a sector median of 6.0 days. The latest filing is dated 2026-11-04 and is of type regulatory_filing, 4 days before the record date. The NASDAQ median latency is 5.0 days and the sector median latency is 4.0 days. The NASDAQ median filing count is 52 and the sector median filing count is 63.0, against which the issuer's 145 filings sit above both.

## Auditor

The auditor of record is Ernst & Young LLP, located in San Mateo, California. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.

## Orderability

The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

No research houses were found on the issuer's own investor-relations page, and the count is 0.

## Open research

No openly published research notes were found, and the count is 0.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The issuer is sealed for the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001759425.json (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/MIRM (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1759425/000175942526000013/mirm-20251231.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/MIRM (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/MIRM · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp